**Core Concept**
Chemotherapy is a treatment approach that uses chemical agents to target and kill cancer cells. The effectiveness of chemotherapy in curing tumors depends on various factors, including the type of cancer, tumor biology, and the patient's overall health.

**Why the Correct Answer is Right**
Leukemias, lymphomas, and certain types of germ cell tumors are highly responsive to chemotherapy. This is because these cancers are characterized by rapidly dividing cells, making them more susceptible to the cytotoxic effects of chemotherapeutic agents. Chemotherapy works by interfering with cell division, inducing DNA damage, and triggering apoptosis in cancer cells. In contrast, solid tumors like breast, lung, and colon cancers are often less responsive to chemotherapy due to their heterogeneous cell populations and resistance mechanisms.

**Why Each Wrong Option is Incorrect**
* **Option A (e.g., Breast Cancer):** While some breast cancers may respond to chemotherapy, they are not typically considered "cured" with this treatment approach alone. Hormone receptor-positive and HER2-positive subtypes may benefit from targeted therapies, but chemotherapy is often used in conjunction with other treatments.
* **Option B (e.g., Prostate Cancer):** Prostate cancer is often treated with androgen deprivation therapy (ADT) and radiation, with chemotherapy reserved for advanced or hormone-refractory disease.
* **Option C (e.g., Brain Tumors):** Chemotherapy can be challenging in brain tumors due to the blood-brain barrier, which limits the delivery of chemotherapeutic agents to the tumor site.

**Clinical Pearl / High-Yield Fact**
The concept of "minimum residual disease" (MRD) is critical in assessing the effectiveness of chemotherapy in hematological malignancies. MRD refers to the presence of cancer cells in the bone marrow or peripheral blood after treatment, indicating a higher risk of relapse.

**Correct Answer: C. Leukemias, lymphomas, and certain types of germ cell tumors.**